Western Cape health officials report a large uptake of lenacapavir, a new HIV prevention injection, with thousands of people starting the treatment in the province. The Western Cape Department of Health and Wellness says that nearly 90% of those who opt for the injection are first-time users, indicating that many participants are new to this form of HIV prevention rather than switching from an earlier regimen. Health authorities describe the trend as a significant development for HIV prevention efforts in the region, suggesting broad interest and a willingness among new users to adopt the injected method. The reports attribute the surge in demand to the introduction of lenacapavir as an option for HIV prevention, and they present first-time participation as an indicator of the injection’s early reach. The information is based on figures provided by the provincial department, which is tracking uptake among clients choosing the injection in the Western Cape.